Clvs institutional ownership

In depth view into CLVS (Clovis Oncology) stock including the latest price, news, dividend history, earnings information and financials. Oct 17, 2019 · Institutions – At the moment, institutional investors hold 0 of CLVS. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months.
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium ... Oct 17, 2019 · Institutions – At the moment, institutional investors hold 0 of CLVS. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months. 9 hours ago · CLVS stock construct a change of 5.24 in a total of its share price and finished its trading at 8.83. Clovis Oncology, Inc. institutional ownership is held at 0.00% while insider ownership was 2.40%. As of now, CLVS has a P/S, P/E and P/B values of 3.75, 0.00 and 0.00 respectively.

2 dimensional vectors

The company develops CO-101, a lipid-conjugated form of the anti-cancer drug gemcitabine, which is in Phase III clinical trials for first-line treatment of metastatic pancreatic cancer; Phase II clinical trials for second-line treatment of metastatic pancreatic cancer; and preclinical trials for solid tumors.
Jan 17, 2020 · Clovis Oncology, Inc. institutional ownership is standing at 0 percent, while insider ownership is 2.5 percent. As of now, CLVS has a P/S, P/E and P/B values of 4.21 , 0 and 0 respectively. Its P/Cash is value at 1.59 . Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium ...

Oct 17, 2019 · Institutions – At the moment, institutional investors hold 0 of CLVS. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months. Nonetheless, it’s important to note that institutional ownership has seen a move of 11.37% in the past 3 months.
Jan 31, 2020 · View today's stock price, news and analysis for Clovis Oncology Inc. (CLVS). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.

Lol combo list 2019

CLVS Stock Institutional Ownership and Insider Ownership - Clovis Oncology : the historical trend of stock ownership among institutions and insiders. Home Homepage Membership Levels Membership Data Coverage Complete Stock List Founder's Message The book Value Investing Forum Podcast Free Trial Insider trades (SEC Form 4) for Clovis Oncology, Inc. (CLVS). Displays all buying and selling activity for company insiders.
Institutional Ownership: 69.96%: Total Shares Outstanding (millions) 73: Total Value of Holdings (millions) $435